QS Investors, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2021$371,000
-16.3%
3,8840.0%0.00%
-20.0%
Q1 2021$443,000
-16.6%
3,884
+1.3%
0.01%
-16.7%
Q4 2020$531,000
+65.4%
3,834
-1.7%
0.01%
+50.0%
Q3 2020$321,000
-74.5%
3,900
-75.8%
0.00%
-77.8%
Q2 2020$1,260,000
+76.0%
16,1000.0%0.02%
+63.6%
Q1 2020$716,000
+3.0%
16,1000.0%0.01%
+57.1%
Q4 2019$695,000
+0.9%
16,1000.0%0.01%
-12.5%
Q3 2019$689,000
-32.6%
16,1000.0%0.01%
-27.3%
Q2 2019$1,023,000
+1523.8%
16,100
+1688.9%
0.01%
+1000.0%
Q1 2019$63,000
+57.5%
900
-0.8%
0.00%0.0%
Q4 2018$40,000
-42.0%
9070.0%0.00%0.0%
Q3 2018$69,000
-1.4%
9070.0%0.00%0.0%
Q2 2018$70,000
+52.2%
9070.0%0.00%
Q1 2018$46,000
+9.5%
9070.0%0.00%
Q4 2017$42,000
-12.5%
9070.0%0.00%
Q3 2017$48,000
-14.3%
9070.0%0.00%
Q2 2017$56,000
-8.2%
9070.0%0.00%
-100.0%
Q1 2017$61,000
+6000.0%
907
+12857.1%
0.00%
Q4 2016$1,0000.0%70.0%0.00%
Q3 2016$1,0000.0%7
+40.0%
0.00%
Q2 2016$1,0000.0%5
+66.7%
0.00%
Q4 2015$1,00030.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders